Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
BHA derivative.
Melatonin analog; MT1/2 agonist.
TxA2 antagonist.
c-Raf, RET, VEGFR1 inhibitor, potential HMT inh...
Kavalactone originally found in Piper methystic...
MEK1/2 and ERK inhibitor.
Indole alkaloid found in Evodia rutaecarpa; top...
HSP90 inhibitor.
Somatostatin analog, peptide; somatostatin agon...
Mycotoxin produced by Fusarium fungi that infec...
Endogenous neuropeptide hormone, lowers extrace...
Peptide, binds heparin.
Dihydropyridine; L-type Ca2+ channel blocker.
Hec1/Nek2 mitotic pathway inhibitor
SERM.
Potential PKD binding agent.
Found in plants in Astragalus, Allium, and Bras...
EGFR inhibitor.
NSAID; COX-1/2 inhibitor.
B-Raf and c-Raf inhibitor.